DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 42 · September 2009 DOI: 10.1055/s-002-20375


26th Symposium of the AGNP
Munich, 7.–10. October 2009

Chairs: Christoph Hiemke, Mainz – Beate Schlösser, Wedel – Rainer Rupprecht, Munich
Abstracts (HTML) List of Authors
Editorial
Hiemke, C; Schlösser, B; Rupprecht, R: Editorial
A1
Abler, B; Hahlbrock, R; Unrath, A; Groen, G; Kassubek, J: Pathological gambling associated with dopamine agonists: predisposing neurobiology investigated with fMRI
A2
Arlt, S; Brassen, S; Wilke, F; Eichenlaub, M; Apostolova, I; Buchert, R; Jahn, H: Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease
A3
Arlt, S; Schulze, F; Eichenlaub, M; Maas, R; Wiedemann, K; Böger, R; Jahn, H: Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease
A4
Avrabos, C; Hambsch, B; Zieglgänsberger, W; Landgraf, R; Eder, M: Electrophysiological correlates of trait anxiety in mice
A5
Baier, PC; Hallschmid, M; Seeck-Hirschner, M; Burkert, S; Diessner, N; Göder, R; Aldenhoff, JB; Hinze-Selch, D: Intranasal orexin A (hypocretin-1) restores the key REM-sleep abnormalities in human narcolepsy with cataplexy
A6
Baier, PC; Weinhold, S; Huth, V; Gottwald, B; Ferstl, R; Hinze-Selch, D: Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1)
A7
Bajoghli, H; Holsboer-Trachsler, E; Brand, S: Perception and importance of Hafez's poetry of love in modern Iran and Switzerland
A8
Beck, J; Hemmeter, U; Brand, S; Muheim, F; Hatzinger, M; Holsboer-Trachsler, E: Modafinil reduces microsleep during partial sleep deprivation and improves antidepressant treatment response
A9
Beitinger, PA; Fulda, S; Wehrle, R; Himmerich, H; Wetter, TC: Disturbed eating behaviour in patients with narcolepsy
A10
Benninghoff, J; Genius, J; Möller, HJ; Vescovi, A; Rujescu, D: Impact of 5HT1A receptor subtype on adult neural stem cells derived from murine hippocampus
A11
Bertram, S; Zhang, W; Toyka, KV; Hatt, H; Eder, M; Buchwald, B: Immunoglobulin G from patients with chronic inflammatory demyelinating polyneuropathy (CIDP) affects presynaptic transmitter release and calcium influx
A12
Bonn, M; Nietzer, SL; Jansen, F; Heiming, R; Winnig, M; Sachser, N; Lesch, KP; Asan, E; Schmitt, AG: Genotype-dependent and stress-related morphological changes of neurons in the brain of wildtype and serotonin transporter knockout mice
A13
Bonnet, U; Wiemann, M: Modulatory effects of various neuropsychopharmaca on intracellular pH of hippocampal CA3-neurons in vitro (guinea pig)
A14
Born, C; Dittmann, S; Biedermann, C; Seemüller, F; Amann, B; Grunze, H; Schärer, LO: Validity of the National Institutes of Mental Health Life Chart self version (NIHM-sLCM)
A15
Boxleitner, M; Giegling, I; Hartmann, AM; Genius, J; Ruppert, A; Möller, HJ; Rujescu, D: Genetic association study in schizophrenia and intermediate phenotypes
A16
Brand, S; Djurdjevic, A; Beck, J; Gerber, M; Hatzinger, M; Holsboer-Trachsler, E: Evidence of favorable sleep EEG patterns in adolescent male vigorous football players compared to controls
A17
Brand, S; Gerber, M; Beck, J; Hatzinger, M; Holsboer-Trachsler, E: „Adolescent regular exercisers are better human beings!“
A18
Brand, S; Hatzinger, M; Beck, J; Holsboer-Trachsler, E: Long-term treatment of patients suffering from Restless Legs syndrome does not improve satisfaction with life and sleep compared to healthy controls
A19
Brückl, T; Lieb, R; Pfister, H; Wittchen, HU; Holsboer, F; Ising, M; Zimmermann, P: Polymorphisms in the serotonin receptor 2A gene (HTR2A), parenting styles and the risk of depression in young adulthood: results from a family study
A20
Brühl, A; Herwig, U: Differential modulation of emotion processing by single dose serotonergic and noradrenergic antidepressants – a pharmaco-fMRI study
A21
Brünen, S; Hiemke, C; Finger, S; Korf, F; Jahn, H; Wiedemann, K; Kiefer, F: Therapeutic drug monitoring of naltrexone in alcohol dependent patients
A22
Bührsch, NC; Swoboda, U; Quante, A; Zeugmann, S; Bajbouj, M; Anghelescu, I; Heuser, I: Cortisol awakening reaction in depressed patients with and without early life stress
A23
Christian, L; Golub, Y; Rein, T; Wotjak, CT; Schmidt, U: Biomarkers in a mouse model of posttraumatic stress disorder
A24
de Arce, R; Eding, E; Marques, T; Milanova, V; Rancans, E; Ibach, B; Schreiner, A: Descriptive analysis of the Aripiprazole arm in the Risperidone long-acting injectable vs. Quetiapine relapse prevention trial (constaTRE)
A25
Del Campo, N; Fryer, TD; Hong, YT; Izquierdo, D; Smith, R; Chamberlain, SR; Dowson, J; Craig, K; Regenthal, R; Aigbirhio, FI; Baron, JC; Robbins, TW; Sahakian, BK; Müller, U: Effects of oral methylphenidate on [18F]fallypride binding in healthy volunteers and adults with attention-deficit hyperactivity disorder (ADHD)
A26
Demiralay, C; Zorawski, M; Wiedemann, K; Jahn, H: „A chemical love story“: Treatment of a gamma-butyrolacton (GBL)-dependent chemistry student with diazepam – a case report
A27
Demiralay, C; Wiedemann, K; Kellner, M; Yassouridis, A; Jahn, H: Influence of exogenous ANP on the nocturnal HPA axis and sleep in healthy men
A28
Devigny, C; Perez-Balderas, F; Hoogeland, B; Hausch, F: Biomimetic screening of CRHR ligands
A29
Ditzen, C; Varadarajulu, J; Czibere, L; Gonik, M; Bunck, M; Teplytska, L; Müller-Myhsok, B; Holsboer, F; Landgraf, R; Turck, CW: Proteomic genotyping in a mouse model of trait anxiety exposes disease relevant pathways
A30
Dodds, CM; Clark, L; Dove, A; Regenthal, R; Baumann, F; Bullmore, ET; Robbins, TW; Müller, U: Sulpiride modulates striatal BOLD signal during the manipulation of information in working memory
A31
Dresler, M; Genzel, L; Kluge, M; Schüssler, P; Steiger, A: A double dissociation of memory impairments in major depression
A32
Dresler, M; Genzel, L; Kluge, M; Schüssler, P; Steiger, A: A double dissociation of memory impairments in major depression
A33
Dresler, M: Sleep-associated memory disorders in depression
A34
Eckert, GP; Hooff, GP; Strandjord, DM; Igbavboa, U; Volmer, DA; Müller, WE; Wood, WG: Regulation of the brain isoprenoids farnesyl- and geranylgeranyl-pyrophosphate is altered in male Alzheimer patients
A35
Eichenlaub, M; Arlt, J; Steigert, J; Arlt, S; Yassouridis, A; Jahn, H: The influence of galantamine on heart rate variability (HRV)
A36
Ettinger, U; Williams, SCR; Patel, D; Michel, TM; Nwaigwe, A; Caceres, A; Mehta, MA; Anilkumar, A; Kumari, V: Effects of acute nicotine on brain function in healthy smokers and non-smokers:estimation of inter-individual response heterogeneity
A37
Filiou, MD; Zhang, YY; Bisle, B; Frank, E; Kessler, MS; Teplytska, L; Reckow, S; Haegler, K; Maccarrone, G; Hambsch, B; Landgraf, R; Turck, CW: Stable isotope metabolic labeling of a mouse model reveals synaptic biomarkers for anxiety disorders
A38
Finke, K; Dodds, CM; Bublak, P; Regenthal, R; Baumann, F; Manly, T; Müller, U: Plasma level-dependent effects of methylphenidate and modafinil on processing speed and short term memory capacity parameters of the theory of visual attention (TVA) task
A39
Gassen, N; Han, Y; Rein, T: Functional impact of FKBP5 on the phosphatase calcineurin
A40
Gassner, LM; Kiermeir, J; Siebörger, A; Adli, M: Effects of Euthymic Psychotherapy on Depression
A41
Genius, J; Giegling, I; Möller, HJ; Rujescu, D: Alterations in the Ca2+ homeostasis in lymphocytes from schizophrenic patients
A42
Giegling, I; Hartmann, AM; Möller, HJ; van den Oord, E; Rujescu, D: Neuroticism as a risk factor for suicidal behavior
A43
Giegling, I; Hartmann, AM; Schneider, B; Schnabel, A; Maurer, K; Möller, HJ; Rujescu, D: Genetics of aggression and impulsiveness as risk factors for suicidal behavior
A44
Giegling, I; Hartmann, AM; Genius, J; Boxleitner, M; Ruppert, A; Möller, HJ; Rujescu, D: Connecting genomic findings in schizophrenia and intermediate phenotypes
A45
Golub, Y; Mauch, CP; Pamplona, F; Wotjak, CT: The role of time-dependent memory processes in the development of PTSD-like symptoms in mice
A46
Goppel, S; Stephan, P; Bitter, J; Hemmeter, U: Disease or drug? Confusion, stupor and muscular hypertension in a 56-year-old woman with bipolar disorder under established psychopharmacological therapy: a case report
A47
Goya-Maldonado, R; Spoormaker, VI; Chechko, N; Höhn, D; Andrade, K; Kluge, M; Steiger, A; Holsboer, F; Czisch, M; Sämann, PG: Subregional amygdala functional connectivity: normative maps and influence of oral citalopram in healthy volunteers
A48
Griffith, L; Müller, C: The role of Cytochrome P450 genetic disposition and patient reaction to therapy in a cohort controlled study in private practice-preliminary results from the MORE study
A49
Gruber, O; Diekhof, EK: When desire collides with reason: functional interactions between anteroventral prefrontal cortex and nucleus accumbens underlie the human ability to resist impulsive desires
A50
Günther, T; Hesse, S; Kendziorra, K; Barthel, H; Sander, C; Olbrich, S; Adamaszek, M; Becker, G; Sabri, O; Hegerl, U; Schönknecht, P: EEG-based vigilance and cerebral glucose metabolism – a parallel EEG and FDG PET study
A51
Hader, A; Haen, E: In what way dose-related and therapeutic reference ranges are different and what is the use of them?
A52
Hahn, A; Lanzenberger, R; Spindelegger, C; Stein, P; Mien, LK; Savli, M; Akimova, E; Mitterhauser, M; Wadsak, W; Kasper, S: Enhanced association of pre- to postsynaptic serotonin-1A receptors through escitalopram treatment in anxiety disorder patients
A53
Hanstein, R; Trotter, J; Behl, C; Clement, AB: Interaction of BDNF and Connexin43– two downstream targets of CRH-activated gene transcription
A54
Hartmann, AM; Giegling, I; Genius, J; Schäfer, M; Bondy, B; Möller, HJ; Rujescu, D: Pharmacogenetics of antipsychotics using an animal model
A55
Hartmann, J; Wagner, K; Liebl, C; Wolf, M; Scharf, S; Wang, XD; Harbich, D; Mayer, B; Rein, T; Schmidt, U; Hausch, F; Smith, D; Cox, MB; Müller, MB; Schmidt, MV: The involvement of FKBP5 in the behavioural and neuroendocrine effects of acute and chronic stress
A56
Heck, A; Szesny, N; Holsboer, F; Reppermund, S; Ising, M: Polymorphisms of the dopamine beta-hydroxylase (DBH) gene show associations with cognitive flexibility in mentally healthy adults
A57
Heinzmann, JM; Thöringer, CK; Palme, R; Landgraf, R; Touma, C: Temporal aspects of HPA axis reactivity and regulation: microdialysis studies in the HR/IR/LR mouse model
A58
Henes, K; Wotjak, CT: Traces of a trauma – Long-lasting changes in brain activity in an animal model of PTSD
A59
Hennings, JM; Owashi, T; Binder, EB; Horstmann, S; Menke, A; Kloiber, S; Messer, T; Pollmächer, T; Nickel, T; Sonntag, A; Uhr, M; Ising, M; Holsboer, F; Lucae, S: Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature project
A60
Hinkelmann, K; Moritz, S; Botzenhardt, J; Riedesel, K; Wiedemann, K; Kellner, M; Otte, C: Cognitive impairment in major depression: Association with circadian salivary cortisol
A61
Hinkelmann, K; Yassouridis, A; Mass, R; Tenge, H; Kellner, M; Jahn, H; Wiedemann, K; Wolf, K: CCK-4 effects upon facial expression in healthy subjects
A62
Hintzen, A; Cramer, J; Karaguelle, D; Frieling, H; Bleich, S; Hillemacher, T: CDT and homocysteine as predictors for alcohol withdrawal seizures
A63
Höhn, D; Spoormaker, VI; Czisch, M; Sämann, PG: FMRI based resting state networks challenged as predictors of stress coping styles and personality traits in healthy volunteers
A64
Holfelder, C; Eder, M; Becker, K; Zieglgänsberger, W; Buchwald, B: Semicarbazide modulates cortical excitation in mouse brain slices
A65
Holthoewer, D; Hiemke, C; Schmitt, U: Influence of P-glycoprotein (P-gp) induction on the pharmacokinetics of risperidone and paliperidone in mouse brain
A66
Hornung, O: Sleep and memory consolidation in the elderly
A67
Horstmann, S; Menke, A; Hennings, JM; Lucae, S; Straub, V; Spieler, D; Wollweber, B; Holsboer, F; Binder, EB: Association of the adrenergic receptor alpha1B with antidepressant treatment in the MARS study
A68
Ibach, B; Kühn, F; Gerwe, M; Diekamp, B: Galantamine improves non-cognitive symptoms as compared to nootropics in outpatients with mild to moderate Alzheimer's disease
A69
Ising, M; Lucae, S; Binder, EB; Bettecken, T; Uhr, M; Ripke, S; Kohli, MA; Hennings, JM; Horstmann, S; Kloiber, S; Menke, A; Bondy, B; Rupprecht, R; Domschke, K; Baune, BT; Arolt, V; Rush, AJ; Holsboer, F; Müller-Myhsok, B: A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression
A70
Jakob, S; Ortega, G; Schmitt, AG; Kenis, G; Steinbusch, H; Prickaerts, J; Lesch, KP; van den Hove, DLA: The psychopathology of prenatal stress: The role of epigenetic regulation of brain-derived neurotrophic factor (BDNF) promoter
A71
Kaiser, E; Thomann, PA; Seidl, U; Schröder, J: CSF-concentrations of tau-protein, phospho-tau-protein (181) and amyloid-beta (1–42) in patients with stable and non-stable MCI
A72
Kaiser, E; Schönknecht, P; Kassner, S; Hildebrandt, W; Kinscherf, R; Schröder, J: Concentrations of functionally important amino acids in cerebrospinal fluid of patients with Alzheimer's disease compared to mild cognitive impairment
A73
Kaiser, E; Schönknecht, P; Kassner, S; Hildebrandt, W; Kinscherf, R; Schröder, J: Cerebrospinal fluid concentrations of functionally important amino acids in patients with Alzheimer's disease compared to mild cognitive impairment
A74
Kaltwasser, SF; Golub, Y; Mauch, CP; Czisch, M; Wotjak, CT: Reduction of hippocampal volume after traumatic experience can be prevented by enriched environment
A75
Kellner, M; Muhtz, C; Demiralay, C; Husemann, J; Koelsch, W; Yassouridis, A; Wiedemann, K: Serotonergic modulation of experimental panic elicited by cholecystokinin tetrapeptide in healthy man
A76
Keßler, U; Linden, M: Standardized decision algorithm for selecting the next antidepressant using information on previous treatments: THE-Checklist
A77
Kirmeier, T; Ganal, V; Ranganath, G; Flachskamm, C; Maccarrone, G; Turck, CW; Hausch, F; Holsboer, F; Rein, T: Modified antidepressants as innovative tools for identifying novel drug targets
A78
Klein, JP; Scheibe, C; Wüstenberg, T; Heuser, I; Heekeren, HR; Colla, M: Implicit and explicit processing of facial emotion involves distinct neural pathways
A79
Kloiber, S; Kohli, MA; Brückl, T; Ripke, S; Ising, M; Uhr, M; Menke, A; Unschuld, PG; Horstmann, S; Salyakina, D; Müller-Myhsok, B; Binder, EB; Holsboer, F; Lucae, S: Polymorphisms in tryptophan hydroxylase 2 leading to decreased serotonergic activity contribute to elevated risk for metabolic syndrome in depression
A80
Klomp, M; Rademacher, L; Raptis, M; Spreckelmeyer, KN; Vernaleken, I; Rösch, F; Schäfer, WM; Gründer, G: In vivo dopamine D2 receptor binding and personality traits in healthy volunteers: an 18F-Fallypride PET study
A81
Kluge, M; Schüssler, P; Schmid, D; Uhr, M; Kleyer, S; Yassouridis, A; Steiger, A: Ghrelin plasma levels are not altered in major depression
A82
Knapp, RT; Konzany, C; Weidinger, E; Hafner, K; Holsboer, F; Hausch, F; Rein, T: Steroid receptor folding and signaling is regulated by the Hsp70 cochaperones BAG-1M and HspBP1
A83
Koller, G; Zill, P; Pogarell, O; Bondy, B; Soyka, M: No association of alcohol dependence with SLC6A5 and SLC6A9 glycine transporter polymorphisms
A84
Konnerth, H; Giegling, I; Hartmann, AM; Genius, J; Ruppert, A; Möller, HJ; Rujescu, D: Neuropsychological intermediate phenotypes as tools for genetic studies in schizophrenia
A85
Konte, B; Giegling, I; Hartmann, AM; Konnerth, H; Muglia, P; Ruppert, A; Möller, HJ; Rujescu, D: Genome wide association study on memory in schizophrenia patients and unaffected probands
A86
Konte, B; Giegling, I; Hartmann, AM; Konnerth, H; Muglia, P; Ruppert, A; Möller, HJ; Rujescu, D: Genome wide association study on cognitive performance
A87
Kozany, C; März, A; Kreß, C; Hoogeland, B; Hausch, F: Development of specific inhibitors for the FK506 binding proteins 51 and 52
A88
Krusche, E; Lange, C; Ising, M; Uhr, M; Adli, M: The influence of psychosocial factors on the neurobiological stress mechanism in patients with remitted depression
A89
Kühn, C; Jusyte, A; Schönenberg, M: Posttraumatic stress reactions and HPA system regulation in patients with acute spinal cord injury: a repeated measures approach
A90
Kundermann, B; Hemmeter-Spernal, J; Strate, P; Huber, MT; Gebhardt, S; Krieg, JC; Lautenbacher, S: Pain sensitivity in major depression: relationships to central serotoninergic functions as reflected by the neuroendocrine response to clomipramine
A91
Lange, C; Krusche, E; Bermpohl, F; Ising, M; Uhr, M; Adli, M: The influence of a stress challenge test on the cognitive performance in a Go/No-Go paradigm and its correlation with HPA system dysregulation in healthy subjects and patients with remitted depression
A92
Lang-Rollin, I; Holsboer, F; Rein, T: Can GR function be predicted from the relative cellular amounts of accessory proteins of the GR folding platform?
A93
Lessel, W; Meyer-Lotz, G; Schroeter, ML; Dobrowolny, H; Bernstein, HG; Gos, T; Bogerts, B; Steiner, J: Evidence for a reduced numerical density of S100B-positive astrocytes in depression
A94
Leuner, K; Pantel, J; Schulz, K; Schütt, T; Lipka, U; Eckert, A; Müller, WE: Mitochondrial dysfunction in lymphocytes – a potential biomarker for Alzheimer's disease
A95
Liebl, C; Schmidt, MV; Schülke, JP; Avrabos, C; Trümbach, D; Eder, M; Rein, T; Müller, MB: Functional analysis of a novel, stress-inducible transcript in the mouse brain
A96
Luborzewski, A; Schubert, F; Merkl, A; Quante, A; Bajbouj, M: Metabolite levels in the dorsolateral prefrontal cortex and anterior cingulum of patients with major depression. Comparism with healthy controls and follow-up after a 4-week naturalistic treatment period
A97
Lucae, S; Kohli, MA; Schmidt, MV; Sämann, PG; Demirkan, A; Hek, K; Salyakina, D; Ripke, S; Roeske, D; van Duijn, CM; Uhr, M; Bettecken, T; Holsboer, F; Müller-Myhsok, B; Binder, EB: The neuronal transporter gene SLC6A15 confers risk to major depression
A98
Markt, P; Nußbaumer, M; Touma, C; Landgraf, R: Effects of enriched environment on a mouse model of extremes in trait anxiety
A99
Menke, A; Roeske, D; Domschke, K; Holsboer, F; Binder, EB: Genome-wide association study of antidepressant induced treatment emergent suicidal ideation (TESI)
A100
Mergl, R; Henkel, V; Allgaier, AK; Hautzinger, M; Kohnen, R; Coyne, JC; Hegerl, U: Are treatment preferences relevant for response to serotonergic antidepressants and cognitive-behavioural therapy in depressed primary care patients? Results from a randomized controlled trial including a patient choice arm
A101
Merkl, A; Schneider, GH; Kühn, A; Bührsch, NC; Anghelescu, I; Heuser, I; Bajbouj, M: Deep brain stimulation of the anterior subgenual cingulate (Cg 25) in treatment-resistant depression
A102
Meyer zu Schwabedissen, L; Meyer-Lotz, G; Dobrowolny, H; Gos, T; Myint, AM; Bogerts, B; Steiner, J: Analysis of quinolinic acid-immunopositive microglia in patients with affective disorders: a postmortem study of the anterior cingulate gyrus
A103
Möller, T; Steiger, A; Fahrmeir, L; Yassouridis, A: New statistical ways for analyzing sleep data in clinical and preclinical studies
A104
Muhtz, C; Peter, F; Dunker, S; Wiedemann, K; Yassouridis, A; Kellner, M: DHEA and DHEA-S plasma levels are increased in patients with posttraumatic stress disorder and a history of childhood abuse
A105
Müller, C; Reuter, H; Dohmen, C: Intoxication after extreme oral overdose of quetiapine (36g) to attempt suicide: pharmacological concerns of side effects
A106
Müller, MJ; Scheurich, V; Scheurich, A; Kroukis, W: Acute tryptophan depletion and stress exposure in patients with panic disorder and healthy controls: effects on heart rate variability
A107
Müller, MJ; Scheurich, V; Scheurich, A; Kaltenegger, J: Saliva cortisol concentrations after acute tryptophan depletion and stress exposure in patients with panic disorder and healthy controls
A108
Müller, U; Kitzbichler, M; Wink, AM; Werners, U; Jacob, R; McKenna, P; Regenthal, R; Honey, G; Kerwin, RW; Suckling, J; Bullmore, ET: Aripiprazole and sulpiride have differenzial effects on working memory performance and brain activity in patients with schizophrenia and healthy controls
A109
Mutschler, J; Bilbao, A; der Goltz, C von; Demiralay, C; Jahn, H; Wiedemann, K; Spanagel, R; Kiefer, F: Stress-induced alcohol drinking and withdrawal in mice lacking functional natriruetic peptide-A receptors
A110
Mutschler, J; Grosshans, M; Bühler, M; Diehl, A; Kiefer, F: Disulfiram in the treatment of pathological gambling?
A111
Nazirizadeh, Y; Fischer, V; Pfuhlmann, B; Hiemke, C: Impact of inflammation processes on blood serum levels of olanzapine, quetiapine and risperidone
A112
Netter, P; Toll, C; Siegmund, A; Birkenbach-Holdschuh, T; Lujic, C: Are food and nicotine craving mediated by the same transmitter related drug and respective hormone responses?
A113
Nietzer, SL; Jakob, S; Ortega, G; Kriegebaum, C; Gutknecht, L; Lesch, KP; Schmitt, AG: Male and female stress in serotonin transporter knockout mice
A114
Nocon, A; Hackmann, K; Pfister, H; Heldmann, B; Lucae, S; Rosenhagen, MC; Ising, M: Biomarkers for the combined efficacy of cognitive behavioral therapy in antidepressant treatment in depression
A115
Nothdurfter, C; Tanasic, S; Di Benedetto, B; Rammes, G; Kirmeier, T; Ganal, V; Wagner, E; Rein, T; Rupprecht, R: Impact of lipid raft integrity on 5-HT3 receptor function and its modulation by antidepressants
A116
Obermeier, M; Mayr, A; Schennach-Wolff, R; Seemüller, F; Möller, HJ; Riedel, M: How to handle the PANSS in statistical analyses
A117
Olbrich, S; Eplinius, F; Sander, C; Trenner, M; Claus, S; Schönknecht, P; Hegerl, U: EEG-vigilance in patients with tumor-associated fatigue syndrome in comparison to healthy controls
A118
Olbrich, S; Jahn, I; Claus, S; Trenner, M; Sander, C; Schönknecht, U; Hegerl, U: Effects of methylphenidate on EEG-vigilance in patients with tumor-associated fatigue syndrome
A119
Olbrich, S; Sander, C; Trenner, M; Schönknecht, P; Hegerl, U: Intracortical EEG-vigilance stages and the autonomous nervous system
A120
Otte, C; Hinkelmann, K; Moritz, S; Yassouridis, A; Jahn, H; Wiedemann, K; Kellner, M: Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study
A121
Pagani, L; Moriggi, E; Revell, VR; Hack, LM; Izakovic, J; Lockley, SW; Arendt, J; Wirz-Justice, A; Cajochen, C; Skene, DJ; Brown, SA; Eckert, A: Human molecular circadian rhythms and ageing
A122
Palm, U; Fintescu, Z; Schiller, C; Reisinger, E; Keeser, D; Bondy, B; Padberg, F: BDNF plasma level changes after transcranial direct current stimulation in major depressive disorder
A123
Passie, T: A new classification of the psychoactive substances (stimulants, entactogens, hallucinogens)
A124
Paulzen, M; Spreckelmeyer, KN; Van Waesberghe, J; Zalewski, M; Baltus, T; Raptis, M; Rösch, F; Vernaleken, I; Schäfer, WM; Gründer, G: Low D2/D3-receptor availability in detoxified alcoholics compared to healthy subjects – PET study with [18F]fallypride
A125
Perisic, T; Rein, T; Zschocke, J: The epigenetic status of the GLT-1 promoter is influenced by drugs with histone deacetylase inhibitor properties
A126
Petrovsky, N; Ettinger, U; Quednow, B; Schnell, K; Mössner, R; Walter, H; Maier, W; Wagner, M: Nicotine effects on endophenotypes of schizophrenia
A127
Pfuhlmann, B; Greiner, C; Haen, E; Riederer, P; Deckert, J; Hiemke, C: Effects of age, gender, smoking and co-medication on the pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in everyday clinical practice
A128
Pfuhlmann, B; Hiemke, C; Unterecker, S; Burger, R; Riederer, P; Deckert, J; Jabs, B: The influence of inflammatory reactions on the serum concentration of clozapine
A129
Plendl, W; Wotjak, CT: Fear relief is neither sufficient nor essential for long-term fear extinction
A130
Quante, A; Luborzewski, A; Bührsch, NC; Langosch, J; Zeugmann, S; Born, C; Anghelescu, I; Wolf, J: Aripirazole as adjunct to a mood stabilizer and citalopram in bipolar depression: A randomized, placebo-controlled study
A131
Rademacher, L; Spreckelmeyer, KN; Krach, S; Paulus, F; Gründer, G: Gender differences in social reward anticipation
A132
Rhein, V; Baysang, G; Rao, S; Meier, F; Tripodi, T; Giese, M; Hamburger, M; Müller-Spahn, F; Eckert, A: Ginkgo biloba extract restores amyloid-beta induced mitochondrial deficits
A133
Ricken, R; Wiethoff, K; Todorova, E; Stamm, T; Baghai, TC; Fisher, R; Möller, HJ; Hauth, I; Brieger, P; Cordes, J; Laux, G; Heinz, A; Bauer, M; Adli, M: Is algorithm-guided treatment of depression cost-effective?
A134
Riedel, M; Spellmann, I; Schennach-Wolff, R; Obermeier, M; Musil, R: Validation of a new scale to assess quality of life in schizophrenic patients treated with antipsychotic drugs, the RSM-scale
A135
Rosenhagen, MC; Höhn, D; Schuessler, P; Menke, A; Holsboer, F; Uhr, M: Polymorphisms in the drug transporter gene ABCB1 in treatment resistant depression: clinical practice
A136
Rossenu, S; Mannaert, E; Hargarter, L; Mehnert, A; Vermeulen, A: D2-receptor occupancies and corresponding plasma concentrations: a comparison of paliperidone extended-release (ER) with risperidone immediate-release (IR)
A137
Saglam, H; Tatusch, V; Hiemke, C: Therapeutic drug monitoring of clozapine in schizophrenic outpatients
A138
Sämann, PG; Höhn, D; Holsboer, F; Czisch, M: Proton-MR-spectroscopy (1H-MRS) of the left hippocampus and anterior cingulate cortex in recurrent unipolar depression: results from 176 subjects
A139
Sander, C; Olbrich, S; Arns, M; Hegerl, U: Vigilance regulation as predictor for response to psychostimulants in ADHD
A140
Sartorius, A; Kiening, K; Gall, C von; Haberkorn, U; Unterberg, AW; Henn, FA; Meyer-Lindenberg, A: Psychomodulation by bilateral deep brain stimulation of the lateral habenula in a patient with long-lasting, therapy-refractory major depression
A141
Scharf, SH; Sterlemann, V; Liebl, C; Ganea, K; Weber, P; Pütz, B; Deussing, JM; Rein, T; Müller, MB; Schmidt, MV: Lasting effects of chronic social stress in mice: Impact of antidepressant treatment
A142
Schennach-Wolff, R; Jäger, M; Mayr, A; Seemüller, F; Möller, HJ; Riedel, M: Depressive symptoms and their influence and predictive validity on treatment outcome in patients with first-episode schizophrenia
A143
Schennach-Wolff, R; Zill, P; Jäger, M; Seemüller, F; Obermeier, M; Bondy, B; Möller, HJ; Riedel, M: Outcome of suicidal patients with schizophrenia and the possible genetic association: results from a naturalistic study
A144
Schipke, C; Anghelescu, I; Regen, F; Heuser, I; Peters, O: Antidepressants act on glia cells: Calcium responses of astrocytes to citalopram and fluoxetine in the mouse brain
A145
Schmechtig, A; Vassos, E; Kumari, V; Hutton, SB; Collier, DA; Morris, RG; Williams, SCR; Ettinger, U: Association of Neuregulin 1 rs3924999 with oculomotor endophenotypes for schizophrenia in healthy volunteers
A146
Schmidt, U; Gall-Kleebach, D; Pfister, H; Czesny, N; Spoormaker, VI; Rein, T; Uhr, M; Bettecken, T; Holsboer, F; Ising, M: The Munich PTSD Biomarker Study (MPBS)
A147
Schmidt, U; Touma, C; Gassen, N; Christian, L; Asmus, S; Cox, MB; Hausch, F; Schmidt, MV; Holsboer, F; Rein, T: Deletion of FKBP5 alters stress-related parameters in mice
A148
Schmitt, AG; Hall, FS; Perona, M; Ortega, G; Hofmann, M; Sora, I; Uhl, GR; Riederer, P; Lesch, KP; Gerlach, M; Grünblatt, E: Stress and methylphenidate treatment, both modulate neuronal activity in an animal model for ADHD
A149
Schmitt, U; Schoenfelder, Y; Karlsson, L; Kugelberg, FC; Bengtsson, F; Hiemke, C: Forced swim-test-related antidepressant effects depend on P-glycoprotein expression in the Blood-Brain-Barrier
A150
Schoeneck, L; Movebach, J; Meyer-Lotz, G; Keilhoff, G; Mawrin, C; Dobrowolny, H; Bernstein, HG; Gos, T; Bogerts, B; Steiner, J: Dyregulated expression of the oligodendroglial transcriptionfactor Olig 2 in schizophrenia and depression
A151
Schönfelder, Y; Hiemke, C; Schmitt, U: Consequences of P-gp deficiency for the phenotype of FVB/N (mdr1a/1b -/-) mice and resulting alterations in HPA-System activity
A152
Schülke, JP; Liebl, C; Stiess, M; Zimmermann, N; Schmidt, MV; Avrabos, C; Wochnik, GM; Trümbach, D; Bradke, F; Eder, M; Müller, MB; Rein, T: The novel stress inducible gene MPIP101 modulates neurite formation via changes in Actin dynamics
A153
Schüssler, P; Kluge, M; Dresler, M; Yassouridis, A; Steiger, A: Effects of intravenous corticotropin-releasing hormone upon sleep EEG in young healthy women
A154
Schüssler, P; Kluge, M; Yassouridis, A; Dresler, M; Uhr, M; Steiger, A: Ghrelin levels increase after visual perception of food
A155
Spellmann, I; Rujescu, D; Musil, R; Giegling, I; Mayr, A; Zill, P; Dehning, S; Cerovecki, A; Bondy, B; Müller, N; Möller, HJ; Riedel, M: Pharmacogenetics of therapy response in schizophrenia
A156
Spreckelmeyer, KN; Paulzen, M; Weymanns, A; Van Waesberghe, J; Zalewski, J; Vernaleken, I; Raptis, M; Schaefer, KM; Treede, RD; Baltus, T; Rösch, F; Gründer, G: Low dopamine D2/3 receptor availability is associated with high sensitivity to pain in detoxified alcoholics and healthy controls
A157
Steiner, A; Landgraf, R; Czibere, L: Tmem132d: a novel biomarker for anxiety disorders
A158
Thomann, PA; Kaiser, E; Schönknecht, P; Pantel, J; Essig, M; Schröder, J: Association of CSF total tau and phospho-tau (181) with cerebral atrophy in mild cognitive impairment and Alzheimer's disease
A159
Thum, A; Haag, A; Hermsen, A; Jakobs, H; Rösler, J; Huber, MT; Knake, S; Rosenow, F; Oertel, HM; Hamer, WH: Language dominance and verbal memory in patients with schizophrenia – a study using functional transcranial Doppler sonography (fTCD)
A160
Toro, P; Jilg, H; Sattler, C; Schröder, J: Physical activity as a protective factor in a prospective ageing study in Germany
A161
Toro, P; Sattler, C; Schröder, J: Cognitive leisure activity as a protective factor in a prospective ageing study in Germany
A162
Toro, P; Schönknecht, P; Sattler, C; Schröder, J: Diabetes as a risk faktor for mild cognitive impairment in a population based sample in Germany
A163
Touma, C; Knapman, A; Heinzmann, JM; Fenzl, T; Holsboer, F; Landgraf, R: Mice selected for extremes in stress reactivity: modeling clinically relevant endophenotypes of major depression
A164
Trenner, M; Olbrich, O; Sander, C; Wilk, K; Schönknecht, P; Hegerl, U: EEG-based assessment of wakefulness regulation in patients with mental disorders
A165
Tsolakidou, A; Czibere, L; Pütz, B; Trümbach, D; Panhuysen, M; Deussing, JM; Wurst, W; Sillaber, I; Landgraf, R; Holsboer, F; Rein, T: Stress-induced gene expression in the paraventricular nucleus of hypothalamus in the mouse strains DBA/2J and C57BL/6J – potential signalling pathways involved
A166
Unschuld, PG; Ising, M; Roeske, D; Erhardt, A; Specht, M; Ripke, S; Uhr, M; Kloiber, S; Müller-Myhsok, B; Holsboer, F; Binder, EB: Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients
A167
van Hall, F; Zahn, C; Schommer, N; Anghelescu, I; Heuser, I; Bajbouj, M: rTMS as add-on to escitalopram: a way to enhance antidepressant response? A randomized, placebo controlled trial
A168
Viviani, R; Beschoner, P; Kirchheiner, J; Abler, B: Baseline brain perfusion in schizophrenia revisited: An arterial spin labelling study
A169
Viviani, R; Sim, EJ; Lo, H; Beschoner, P; Osterfeld, N; Seeringer, A; Godoy, AL; Kirchheiner, J; Meier, C: Resting brain perfusion in healthy carriers of the serotonin transporter promoter polymorphism
A170
Wagner, K; Liebl, C; Hartmann, J; Harbich, D; Mayer, B; Wolf, M; Scharf, S; Wang, XD; Schütz, G; Müller, MB; Schmidt, MV: The role of pituitary glucocorticoid receptors in hypothalamic-pituitary-adrenal axis regulation following chronic social stress
A171
Wagner, S; Baskaya, Ö; Anicker, NJ; Dahmen, N; Lieb, K; Tadic, A: The Catechol O-Methyltransferase (COMT) Val158Met polymorphism modulates the association of Serious Life Events (SLE) and impulsive aggression in female patients with Borderline Personality Disorder
A172
Wagner, S; Baskaya, Ö; Lieb, K; Dahmen, N; Tadic, A: The Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism modulates the effects of serious life events on impulsive aggression in patients with Borderline Personality Disorder
A173
Wagner, S; Baskaya, Ö; Lieb, K; Dahmen, N; Tadic, A: The 5-HTTLPR polymorphism modulates the association of Serious Life Events and impulsivity in patients with Borderline Personality Disorder
A174
Walser, SM; Henniger, M; Oldekamp, J; Holsboer, F; Wurst, W; Sillaber, I; Deussing, JM: Functional validation of P2RX7 as a susceptibility marker for depression using humanized mouse mutants
A175
Weber, MM; Burgmair, W: 100 years ago – Psychopharmacotherapy in Emil Kraepelin's Psychiatric Textbook of 1909
A176
Wegerer, M; Adena, S; Binder, EB; Huber, J; Sailer, U; Bettecken, T; Müller-Myhsok, B; Modell, S; Holsboer, F; Ising, M: Polymorphisms within the 4-aminobutyrate aminotransferase gene are associated with long-latency somatosensory potentials in families vulnerable for affective disorders
A177
Weinmann, S; Aderhold, V; Müller-Oerlinghausen, B: Influence of antipsychotics on mortality in schizophrenia: evidence from observational studies
A178
Wiethoff, K; Ricken, R; Baghai, TC; Fisher, R; Möller, HJ; Hauth, I; Brieger, P; Cordes, J; Laux, G; Heinz, A; Bauer, M; Adli, M: Prediction of treatment response in unipolar depression: results from the German Algorithm Project (GAP 3)
A179
Wilhelm, S; Hegerl, U; Linden, M; Quail, D; Wagner, T; Weigmann, H; Schneider, E: Tolerability and safety of duloxetine in a population of depressed patients with painful physical symptoms: results of a 6-month naturalistic study
A180
Wilk, K; Trenner, M; Nägler, K; Schönknecht, P; Hegerl, U: EEG-based assessment of vigilance regulation in patients with depression, and healthy controls
A181
Winder-Rhodes, SE; Chamberlain, SR; Idris, MI; Robbins, TW; Sahakian, BK; Müller, U: Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers
A182
Wolf, M; Wang, XD; Scharf, SH; Liebl, C; Holsboer, F; Müller, MB; Schmidt, MV: Effects of acute and long-term chronic social stress and aging on cognition: involvement of novel synaptic cell adhesion molecules
A183
Wolf, R: Effects of clozapine (CLZ) on reduced prepulse inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats
A184
Wolff, G von; Avrabos, C; Refojo, D; Holsboer, F; Deussing, JM; Eder, M: High-speed voltage-sensitive dye imaging reveals an enhancing effect of corticotropin-releasing hormone (CRH) on neuronal activity propagation through the hippocampal formation
A185
Yen, YC; Sartori, SB; Steiner, A; Singewald, N; Landgraf, R: Pharmacology of neuropeptide S in a mouse model of extremes in anxiety-related behavior
A186
Zavorotnyy, M; Zwanzger, P; Diemer, J; Christ, M; Michael, N; Arolt, V; Pfleiderer, B: Altered Auditive Processing as a Possible Trait-Marker of Major Depressive Disorder
A187
Zill, P; Vielsmeier, V; Büttner, A; Eisenmenger, W; Bondy, B; Möller, HJ: Comparative proteomic analysis with human post mortem brain tissues of drug addicts versus controls: possible impact of beta-tubulin on drug abusing behaviour
A188
Zimmermann, N; Zschocke, J; Bettecken, T; Pütz, B; Holsboer, F; Rein, T: Characterisation of DNA methylation marks in stress exposed hippocampal astrocytes
A189
Zimmermann, P; Brückl, T; Pfister, H; Lieb, R; Wittchen, HU; Holsboer, F; Ising, M; Binder, EB; Uhr, M; Nocon, A: The interplay of variations in the FKBP5 gene and adverse life events in predicting the first onset of depression during a ten-year follow-up
A190
Zschocke, J; Rein, T: Profiling of stress-induced epigenetic alterations in neuronal Neuro-2a cells